Abstract:Immunosuppressive cells play important roles in generating an immunosuppressive tumor microenvironment and facilitating tumor immune escape. However, the molecular mechanisms underlying their immunosuppressive effects remain unclear. UBA3, the sole catalytic subunit of the neural precursor cell expressed developmentally down-regulated protein 8 (NEDD8)-activating enzyme E1, is highly expressed in various human malignancies, along with an activated neddylation pathway. In this study, we investigated the relationships between the UBA3-dependent neddylation pathway and the infiltration of several immunosuppressive cell populations in lung adenocarcinoma (LUAD). We explored the regulatory mechanisms of UBA3 in LUAD cells by using mRNA sequencing and functional enrichment analyses. Correlations between neddylation and immune infiltrates were assessed by Western blotting, real-time PCR, and analyses of public databases. We found elevated levels of UBA3 expression in LUAD tissues compared to adjacent normal tissues. Blocking UBA3 and the neddylation pathway promoted the accumulation of the phosphorylated nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor (p-IκBα), inhibiting the gene expression of tumor cell-derived cytokines such as C–C motif chemokine ligand (CCL) 2, C-X-C motif ligand (CXCL)1, CXCL2, colony-stimulating factor (CSF) 1, CSF2 interleukin (IL)-6, and IL-1B. Moreover, the overexpression of UBA3 in LUAD cells was associated with the secretion of these cytokines, and the recruitment and infiltration of immunosuppressive cells including tumor-associated macrophages (TAMs), plasmacytoid dendritic cells (pDCs), Th2 cells and T-regulatory cells (Tregs). This could facilitate the tumor immune escape and malignant progression of LUAD. Our findings provide new insights into the role of UBA3 in establishing an immunosuppressive tumor microenvironment by modulating nuclear factor kappa B (NF-кB) signaling and the neddylation pathway.

E3 ubiquitin ligase NEDD4L negatively regulates inflammation by promoting ubiquitination of MEKK2

Neddylation Pathway Regulates T-Cell Function By Targeting An Adaptor Protein Shc And A Protein Kinase Erk Signaling

E3 ubiquitin ligase NEDD4L negatively regulates keratinocyte hyperplasia by promoting GP130 degradation

MyD88 NEDDylation Negatively Regulates MyD88-dependent NF-κB Signaling Through Antagonizing Its Ubiquitination.

NDR1 Protein Kinase Promotes IL‐17‐ and TNF‐α‐mediated Inflammation by Competitively Binding TRAF3

E3 ligase Nedd4l promotes antiviral innate immunity by catalyzing K29-linked cysteine ubiquitination of TRAF3

E3 Ubiquitin Ligase Nedd4 Inhibits AP-1 Activity and TNF-α Production Through Targeting P38α for Polyubiquitination and Subsequent Degradation

HECT Domain-containing E3 Ubiquitin Ligase NEDD4L Negatively Regulates Wnt Signaling by Targeting Dishevelled for Proteasomal Degradation

The NEDD8-activating enzyme E1 UBA3 orchestrates the immunosuppressive microenvironment in lung adenocarcinoma via the NF-кB pathway

Rkip Mediates Autoimmune Inflammation By Positively Regulating Il-17r Signaling

E3 Ubiquitin Ligase Nedd4 is a Key Negative Regulator for Non-Canonical Inflammasome Activation

Association Between Neddylation and Immune Response

NEDD4 ubiquitinates TRAF3 to promote CD40-mediated AKT activation

Neddylation Plays an Important Role in the Regulation of Murine and Human Dendritic Cell Function.

Nedd4 Family Interacting Proteins Activate Ubiquitylation Pathways to Limit ERK Signaling Following TCR Engagement (IRM7P.702)

CRL4DCAF2 negatively regulates IL-23 production in dendritic cells and limits the development of psoriasis

Neddylation pathway regulates the proliferation and survival of macrophages.

NEDD4L in human tumors: regulatory mechanisms and dual effects on anti-tumor and pro-tumor

CRL4(DCAF2) Negatively Regulates IL-23 Production in Dendritic Cells and Limits the Development of Psoriasis

NEDD4 and NEDD4L: Ubiquitin Ligases Closely Related to Digestive Diseases

NEDD4 E3 ligase: Functions and mechanism in human cancer